ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/11/07 | 1,850 | 1,863 | 1,835 | 1,838 | -7 | -0.4% | 57,500 |
| 2013/11/06 | 1,859 | 1,860 | 1,835 | 1,845 | -8 | -0.4% | 54,700 |
| 2013/11/05 | 1,840 | 1,858 | 1,812 | 1,853 | +53 | +2.9% | 213,600 |
| 2013/11/01 | 1,784 | 1,810 | 1,705 | 1,800 | +16 | +0.9% | 109,200 |
| 2013/10/31 | 1,775 | 1,794 | 1,761 | 1,784 | -13 | -0.7% | 84,800 |
| 2013/10/30 | 1,835 | 1,845 | 1,781 | 1,797 | -38 | -2.1% | 81,800 |
| 2013/10/29 | 1,850 | 1,850 | 1,800 | 1,835 | +116 | +6.7% | 216,800 |
| 2013/10/28 | 1,755 | 1,773 | 1,691 | 1,719 | -67 | -3.8% | 118,700 |
| 2013/10/25 | 1,782 | 1,813 | 1,760 | 1,786 | -10 | -0.6% | 40,100 |
| 2013/10/24 | 1,801 | 1,818 | 1,761 | 1,796 | +10 | +0.6% | 32,700 |
| 2013/10/23 | 1,825 | 1,843 | 1,780 | 1,786 | -57 | -3.1% | 80,700 |
| 2013/10/22 | 1,830 | 1,845 | 1,806 | 1,843 | +11 | +0.6% | 74,500 |
| 2013/10/21 | 1,830 | 1,849 | 1,810 | 1,832 | -12 | -0.7% | 43,500 |
| 2013/10/18 | 1,807 | 1,844 | 1,798 | 1,844 | +19 | +1% | 45,800 |
| 2013/10/17 | 1,878 | 1,878 | 1,818 | 1,825 | -32 | -1.7% | 45,000 |
| 2013/10/16 | 1,875 | 1,880 | 1,826 | 1,857 | +16 | +0.9% | 40,000 |
| 2013/10/15 | 1,792 | 1,860 | 1,792 | 1,841 | +40 | +2.2% | 96,500 |
| 2013/10/11 | 1,821 | 1,847 | 1,790 | 1,801 | -6 | -0.3% | 66,800 |
| 2013/10/10 | 1,883 | 1,883 | 1,790 | 1,807 | -53 | -2.8% | 47,400 |
| 2013/10/09 | 1,786 | 1,898 | 1,786 | 1,860 | +25 | +1.4% | 51,000 |
| 2013/10/08 | 1,841 | 1,850 | 1,786 | 1,835 | -46 | -2.4% | 64,500 |
| 2013/10/07 | 1,940 | 1,954 | 1,845 | 1,881 | -63 | -3.2% | 109,600 |
| 2013/10/04 | 1,986 | 2,005 | 1,909 | 1,944 | -51 | -2.6% | 133,900 |
| 2013/10/03 | 1,972 | 2,040 | 1,970 | 1,995 | +63 | +3.3% | 152,500 |
| 2013/10/02 | 1,905 | 1,960 | 1,855 | 1,932 | +7 | +0.4% | 161,200 |
| 2013/10/01 | 1,819 | 1,971 | 1,819 | 1,925 | +150 | +8.5% | 200,900 |
| 2013/09/30 | 1,820 | 1,828 | 1,762 | 1,775 | -55 | -3% | 100,700 |
| 2013/09/27 | 1,815 | 1,846 | 1,808 | 1,830 | +30 | +1.7% | 135,300 |
| 2013/09/26 | 1,775 | 1,800 | 1,715 | 1,800 | +53 | +3% | 127,900 |
| 2013/09/25 | 1,782 | 1,795 | 1,727 | 1,747 | -35 | -2% | 71,200 |
| 2013/09/24 | 1,800 | 1,811 | 1,782 | 1,782 | -41 | -2.2% | 77,400 |
| 2013/09/20 | 1,860 | 1,868 | 1,811 | 1,823 | -27 | -1.5% | 147,500 |
| 2013/09/19 | 1,643 | 1,910 | 1,630 | 1,850 | +327 | +21.5% | 939,600 |
| 2013/09/18 | 1,523 | 1,523 | 1,523 | 1,523 | -400 | -20.8% | 145,300 |
| 2013/09/17 | 1,908 | 1,930 | 1,905 | 1,923 | +17 | +0.9% | 35,700 |
| 2013/09/13 | 1,877 | 1,921 | 1,877 | 1,906 | +29 | +1.5% | 55,900 |
| 2013/09/12 | 1,897 | 1,897 | 1,855 | 1,877 | -19 | -1% | 61,400 |
| 2013/09/11 | 1,891 | 1,927 | 1,891 | 1,896 | -10 | -0.5% | 86,000 |
| 2013/09/10 | 1,935 | 1,967 | 1,888 | 1,906 | +3 | +0.2% | 57,000 |
| 2013/09/09 | 1,910 | 1,910 | 1,870 | 1,903 | +48 | +2.6% | 36,400 |
| 2013/09/06 | 1,881 | 1,904 | 1,854 | 1,855 | -59 | -3.1% | 40,900 |
| 2013/09/05 | 1,956 | 1,975 | 1,914 | 1,914 | -41 | -2.1% | 39,200 |
| 2013/09/04 | 1,880 | 1,970 | 1,876 | 1,955 | +75 | +4% | 93,800 |
| 2013/09/03 | 1,850 | 1,889 | 1,844 | 1,880 | +66 | +3.6% | 68,600 |
| 2013/09/02 | 1,839 | 1,879 | 1,800 | 1,814 | -15 | -0.8% | 63,400 |
| 2013/08/30 | 1,743 | 1,832 | 1,737 | 1,829 | +76 | +4.3% | 102,100 |
| 2013/08/29 | 1,860 | 1,884 | 1,750 | 1,753 | -77 | -4.2% | 71,300 |
| 2013/08/28 | 1,840 | 1,910 | 1,785 | 1,830 | -81 | -4.2% | 60,100 |
| 2013/08/27 | 1,838 | 1,964 | 1,838 | 1,911 | +33 | +1.8% | 43,900 |
| 2013/08/26 | 1,810 | 1,892 | 1,810 | 1,878 | +75 | +4.2% | 49,500 |
2701～
2750
件表示中 / 6841件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 72,100円 | -3.7% | -36.7% | 2.77% | 23.74倍 | 1.55倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 113,600円 | +197.7% | - | 0.00% | 46.42倍 | 1.49倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,500円 | +3.2% | +4.5% | 3.48% | 17.17倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 210,500円 | +0.4% | -8.4% | 2.52% | 27.82倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| サンバイオ | 97,900円 | - | - | 0.00% | - | 49.29倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
